XML 33 R25.htm IDEA: XBRL DOCUMENT
v3.26.1

Stock-based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Stock-based Compensation | Note 13. Stock-based Compensation Stock Options The Company maintains the 2016 Stock Incentive Plan and the 2021 Incentive Award Plan (the “Stock Plans”) under which incentive stock options, non-qualified stock options and RSUs may be granted to employees. Under the Stock Plans, the Company has 405,221 shares available for issuance as of December 31, 2025. Under the terms of the Stock Plans, incentive stock options must have an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options are permitted to be granted below fair market value of the stock on the date of grant. The majority of stock options granted have service-based vesting conditions only. The service-based vesting conditions vary though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a ten-year period to exercise the options before they expire. The following table summarized the stock option activity and related information under all stock option plans:
|  | Number of Options |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Life (Years) |  |  | Aggregate Intrinsic Value (in thousands) |
Outstanding as of December 31, 2022 |  |  | 2,686,835 |  |  | $ | 3.34 |  |  |  | 6.77 |  |  | $ | 11,593 |
Exercised |  |  | (131,444 | ) |  |  | 1.80 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (140,661 | ) |  |  | 14.26 |  |  |  | — |  |  |  | — |
Outstanding as of December 31, 2023 |  |  | 2,414,730 |  |  | $ | 2.79 |  |  |  | 5.73 |  |  | $ | 4,004 |
Exercised |  |  | (43,660 | ) |  |  | 1.81 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (398 | ) |  |  | 2.74 |  |  |  | — |  |  |  | — |
Outstanding as of December 31, 2024 |  |  | 2,370,672 |  |  | $ | 2.81 |  |  |  | 4.75 |  |  | $ | 6,055 |
Exercised |  |  | (54,255 | ) |  |  | 2.36 |  |  |  | — |  |  |  | — |
Outstanding as of December 31, 2025 |  |  | 2,316,417 |  |  | $ | 2.81 |  |  |  | 3.76 |  |  | $ | 24,431 |
Vested and exercisable as of December 31, 2025 |  |  | 2,313,355 |  |  | $ | 2.80 |  |  |  | 3.75 |  |  | $ | 24,431 |
Vested and expected to vest as of December 31, 2025 |  |  | 2,316,417 |  |  | $ | 2.81 |  |  |  | 3.76 |  |  | $ | 24,431 |
The intrinsic value of options exercised during years ended December 31, 2025, 2024 and 2023 was $24.4 million, $0.1 million, and $0.5 million, respectively. As of December 31, 2025, the Company had no unrecognized stock-based compensation expense related to the stock options. Restricted Stock Units (“RSUs”) and Performance-based Restricted Stock Units (“PBRSUs”) Beginning November 2020, the Company granted RSUs and PBRSUs to certain employees and consultants pursuant to the 2016 Plan and 2021 Plan. RSUs typically vest 25 percent upon the one-year anniversary date from the initial vesting date, with 12.5% vesting on each six-month anniversary date over the following three years. The RSUs are subject to time-based vesting conditions. PBRSUs are subject to a time-based vesting condition and a performance condition or market condition. In May 2023, the Company granted a total of 1,176,471 P BRSUs pursuant to the 2021 Incentive Award Plan to certain executives that vest on achieving certain operational milestones as defined in the individual grant agreements subject to continued employment through 2025. Stock-based compensation expense is recognized over the expected performance/service achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. If satisfaction of the performance condition is not probable, stock-based compensation cost recognition is deferred until it becomes probable. The Company reassesses the probability as to whether satisfaction of the performance condition is prob able on a quarterly basis, and stock-based compensation cost is adjusted based on the portion of the requisite service provided. These PBRSUs neither carry rights to dividends nor voting rights until the shares are issued or transferred to the recipient. Awards are forfeited if an employee leaves the Company before the PBRSUs vest or the performance period lapses. The weighted-average grant date PBRSU fair value of $5.10 per share is determined based upon the market closing price of the Company’s co mmon stock on the date of grant. These performance-based RSUs were fully vested and released on December 31, 2025 pursuant to the satisfaction of service condition. In May 2023, the Company also granted a total of 735,294 market-based PBRSUs pursuant to the 2021 Incentive Award Plan to certain executives that vest over a multi-year period, upon continue service and when the volume-weighted average price per share (“VWAP Average”) of the Company’s common stock for the preceding 30 consecutive trading days equals or exceeds the target stock price for the indicated year. The Company recognizes stock-based compensation based upon the grant date fair value on an accelerated attribution basis over the requisite service period of the award. Provided that the requisite service is rendered, the total fair value of the market-based PBRSUs at the date of grant is recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria. These PBRSUs neither carry rights to dividends nor voting rights until the shares are issued or transferred to the recipient. Awards are forfeited if an employee leaves the Company before the PBRSUs vest. The weighted-average grant date fair value of the market-based PBRSUs was $1.40 per share. The Company estimated the fair value of the market-based PBRSUs award on the grant date using the Monte Carlo simulation model with the following assumptions:
Expected term (years) |  | 0.5 - 4.7 |
Expected volatility |  |  | 70.9 | %
Risk-free interest rate |  |  | 3.29 | %
Dividend yield |  |  | 0 | %
Share price |  | $ | 5.10 |
As of December 31, 2025, t he total unrecognized compensation expense related to the market-based PBRSUs was $0.3 million, which is expected to be amortized over a weighted-average period of 2.0 years. The following table summarizes the Company’s RSU activity for the year ended December 31, 2025:
|  | Shares |  |  | Weighted Average Grant Date Fair Value per Share |
Outstanding as of December 31, 2022 |  |  | 2,388,909 |  |  | $ | 26.11 |
Granted |  |  | 5,143,160 |  |  |  | 6.04 |
Released |  |  | (1,205,704 | ) |  |  | 18.87 |
Forfeited |  |  | (1,126,554 | ) |  |  | 18.21 |
Outstanding as of December 31, 2023 |  |  | 5,199,811 |  |  | $ | 9.65 |
Granted |  |  | 4,502,661 |  |  |  | 3.57 |
Released |  |  | (1,921,646 | ) |  |  | 10.91 |
Forfeited |  |  | (1,230,957 | ) |  |  | 7.63 |
Outstanding as of December 31, 2024 |  |  | 6,549,869 |  |  | $ | 5.48 |
Granted |  |  | 4,709,367 |  |  |  | 7.90 |
Released |  |  | (2,799,331 | ) |  |  | 6.65 |
Forfeited |  |  | (1,322,632 | ) |  |  | 6.13 |
Outstanding as of December 31, 2025 |  |  | 7,137,273 |  |  | $ | 6.51 |
The total fair value of restricted stock awards vested for the years ended December 31, 2025, 2024 and 2023, was $45.8 million, $6.5 million, and $6.2 million, respectively. As of December 31, 2025, the Company had $38.8 million of unrecognized stock-based compensation expense related to the RSUs. This cost is expected to be recognized over a weighted average period of 2.5 years. Employee Stock Purchase Plan In November 2022, the Board and the Company’s stockholders adopted the 2022 Employee Stock Purchase Plan (“ESPP”) under whic h 1,831,812 shares were aut horized for issuance. The ESPP permits eligible employees to purchase the Company’s common stock through payroll deduction with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six-month offering period, or the relevant purchase date. In addition, participants are subject to $25,000 annual purchase restriction. No ESPP shares were purchased during 2025. Compensation expense Total stock-based compensation expense by function was as follows (in thousands):
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Cost of revenue |  | $ | 414 |  |  | $ | 279 |  |  | $ | 965 |
Research and development expenses |  |  | 12,794 |  |  |  | 16,657 |  |  |  | 16,760 |
General and administrative expenses |  |  | 7,969 |  |  |  | 5,875 |  |  |  | 5,131 |
Sales and marketing expenses |  |  | 666 |  |  |  | 897 |  |  |  | 819 |
Total |  | $ | 21,843 |  |  | $ | 23,708 |  |  | $ | 23,675 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration